Amantadine in Parkinson's disease: lymphocyte subsets and IL-2 secreting T cell precursor frequencies

Akbar, 1991, The synergy between naive and memory T cells during activation, Immunol. Today, 12, 184, 10.1016/0167-5699(91)90050-4 Asenbaum, 1997, Imaging of dopamine transporters with iodine-123-beta-CIT and SPECT in Parkinson's disease, J. Nucl. Med., 38, 1 Bokor, 1993, Antibody-dependent cell-mediated cytotxicity (ADCC) in Parkinson's disease, J. Neurol. Sci., 115, 47, 10.1016/0022-510X(93)90065-7 Bongioanni, 1997, T-lymphocyte tumor necrosis factor-( receptor binding in patients with Parkinson's disease, J. Neurol. Sci., 149, 41, 10.1016/S0022-510X(97)05382-3 Bongioanni, 1997, T-lymphocyte immuno-interferon binding in parkinsonian patients, J. Neural. Transm., 104, 199, 10.1007/BF01273181 Born, 1991, The role of γδ T lymphocytes in infection, Curr. Opin. Immunol., 3, 455, 10.1016/0952-7915(91)90002-I Brücke, 1997, Measurement of the dopaminergic degeneration in Parkinson's disease with [123 I] beta-CIT and SPECT. Correlation with clinical findings and comparison with multiple system atrophy and progressive supranuclear palsy, J. Neural. Transm. Suppl., 50, 9, 10.1007/978-3-7091-6842-4_2 Brücke, 1997, Quantification of dopaminergic nerve cell loss in Parkinson's disease and aging with [123 I] β-CIT and SPECT, 195 Clark, 1989, The antiviral drug amantadine has a direct inhibitory effect on T-lymphocytes, Immunopharmacology, 18, 195, 10.1016/0162-3109(89)90017-9 Conrad, B., Ceballos-Baumann, A.O., 1996. Bewegungsstörungen in der Neurolgie. Georg Thieme Verlag. Stuttgart, New York (in German). Davies, 1964, Antiviral activity of 1-Adamantanamine (Amantadine), Science, 144, 862, 10.1126/science.144.3620.862 Doherty, 1997, Consequences of viral infections for lymphocyte compartmentalization and homeostasis, Semin. Immunol., 9, 365, 10.1006/smim.1997.0094 Fiszer, 1994, Parkinson's disease and immunological abnormalities: increase of HLA-DR expression on monocytes in cerebrospinal fluid and of CD45RO+ T cells in peripheral blood, Acta Neurol. Scand., 90, 160, 10.1111/j.1600-0404.1994.tb02699.x Fiszer, 1994, γδ+ T cells are increased in patients with Parkinson's disease, J. Neurol. Sci., 121, 39, 10.1016/0022-510X(94)90154-6 Fiszer, 1996, V region T cell receptor repertoire in Parkinson's disease, Acta Neurol. Scand., 93, 25, 10.1111/j.1600-0404.1996.tb00165.x Fiszer, 1996, Humoral response to hsp 65 and hsp 70 in cerebrospinal fluid in Parkinson's disease, J. Neurol. Sci., 139, 66, 10.1016/S0022-510X(96)00002-0 Hay, 1992, The action of adamantanamines against influenza A viruses: inhibition of the M2 ion channel protein, Semin. Virol., 3, 21 Hayakawa, 1999, Positive selection of natural autoreactive B cells, Science, 285, 113, 10.1126/science.285.5424.113 Hoehn, 1967, Parkinsonism: onset, progression and mortality, Neurology, 17, 427, 10.1212/WNL.17.5.427 Horowitz, 1999, Viruses, host response, and autoimmunity, Immunol. Rev., 16, 241, 10.1111/j.1600-065X.1999.tb01319.x Klüter, 1995, Defective production of interleukin-2 in patients with idiopathic Parkinson's disease, J. Neurol. Sci., 133, 134, 10.1016/0022-510X(95)00180-A Kuhn, 1995, Neuroimmune mechanisms in Parkinson's disease, J. Neural. Transm. Suppl., 46, 229 Kuhn, 1997, The neuroimmune hypothesis in Parkinson's disease, Rev. Neurosci., 8, 29, 10.1515/REVNEURO.1997.8.1.29 Lang, 1998, Parkinson's disease, N. Engl. J. Med., 339, 1044, 10.1056/NEJM199810083391506 Lang, 1998, Parkinson's disease, N. Engl. J. Med., 339, 1130, 10.1056/NEJM199810153391607 Martilla, 1985, Immune functions in Parkinson's disease lymphocyte subsets, concanavalin A-induced suppressor cell activity and in vitro immunoglobulin production, J. Neurol. Sci., 69, 121, 10.1016/0022-510X(85)90127-3 Moller, 1989, Parkinson's disease and autoimmunity, Acta Neurol. Scand., 79, 173, 10.1111/j.1600-0404.1989.tb03733.x Panzer, 1996, Xenotransplantation: induction of immune tolerance by intravenous immunoglobulin, 249 Panzer-Grumayer, 1993, Characterization of CD7+CD19+ lymphoid cells after Epstein-Barr virus transformation., J. Immunol., 151, 92, 10.4049/jimmunol.151.1.92 Rolak, 1997 Rudd, 1989, Molecular interactions, T-cell subsets and a role of the CD4/CD8:p561ck complex in human T-cell activation, Immunol. Rev., 111, 225, 10.1111/j.1600-065X.1989.tb00548.x Sanders, 1988, Human naive and memory T cells: reinterpretation of helper-inducer and suppressor-inducer subsets, Immunol. Today, 9, 195, 10.1016/0167-5699(88)91212-1 Taswell, 1984, Limiting dilution assays for the determination of immunocompetent cell frequencies. III. Validity tests for the single-hit Poisson model, J. Immunol. Methods, 72, 29, 10.1016/0022-1759(84)90430-7 Theobald, 1992, Host-specific interleukin-2-secreting donor T-cell precursors as predictors of acute graft-versus-host disease in bone marrow transplantation between HLA-identical siblings, N. Engl. J. Med., 327, 1613, 10.1056/NEJM199212033272301 Uitti, 1993, Pathogenesis of idiopathic Parkinsonism, Eur. Neurol., 33, 6, 10.1159/000118533 Wandinger, 1999, Effects of amantadine treatment on in vitro production of interleulin-2 in de-novo patients with idiopathic Parkinson's disease., J. Neuroimmunol., 98, 214, 10.1016/S0165-5728(99)00093-4 Winandy, 1999, Pretransplant helper T-lymphocytes determination in bone marrow donors: acute graft-versus-host disease prediction and relation with long-term survival, British J. Haematology, 105, 288, 10.1111/j.1365-2141.1999.01282.x Youinou, 1999, CD5 expression in human B-cell populations, Immunol. Today, 20, 312, 10.1016/S0167-5699(99)01476-0